CN103320367B - Screening method and application of Escherichia coli for preparing high-yield succinic acids by utilizing synthetic media under anaerobic conditions - Google Patents
Screening method and application of Escherichia coli for preparing high-yield succinic acids by utilizing synthetic media under anaerobic conditions Download PDFInfo
- Publication number
- CN103320367B CN103320367B CN201310288669.0A CN201310288669A CN103320367B CN 103320367 B CN103320367 B CN 103320367B CN 201310288669 A CN201310288669 A CN 201310288669A CN 103320367 B CN103320367 B CN 103320367B
- Authority
- CN
- China
- Prior art keywords
- mgl
- hpo
- escherichia coli
- glucose
- strain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241000588724 Escherichia coli Species 0.000 title claims abstract description 17
- 238000000034 method Methods 0.000 title abstract description 18
- 238000012216 screening Methods 0.000 title abstract description 16
- 235000011044 succinic acid Nutrition 0.000 title abstract 4
- 150000003444 succinic acids Chemical class 0.000 title abstract 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 27
- 239000008103 glucose Substances 0.000 claims abstract description 27
- 230000002194 synthesizing effect Effects 0.000 claims abstract description 9
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 88
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 48
- 239000002609 medium Substances 0.000 claims description 43
- 239000001384 succinic acid Substances 0.000 claims description 42
- 238000000855 fermentation Methods 0.000 claims description 27
- 230000004151 fermentation Effects 0.000 claims description 26
- 239000001963 growth medium Substances 0.000 claims description 26
- 241000894006 Bacteria Species 0.000 claims description 24
- 229960003487 xylose Drugs 0.000 claims description 24
- SRBFZHDQGSBBOR-LECHCGJUSA-N alpha-D-xylose Chemical compound O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-LECHCGJUSA-N 0.000 claims description 17
- 230000000968 intestinal effect Effects 0.000 claims description 17
- 238000011218 seed culture Methods 0.000 claims description 17
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims description 16
- 229910021591 Copper(I) chloride Inorganic materials 0.000 claims description 16
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 claims description 16
- 239000000413 hydrolysate Substances 0.000 claims description 14
- 238000004519 manufacturing process Methods 0.000 claims description 14
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 13
- 210000001072 colon Anatomy 0.000 claims description 13
- 239000007788 liquid Substances 0.000 claims description 13
- 238000011534 incubation Methods 0.000 claims description 12
- OGWLTJRQYVEDMR-UHFFFAOYSA-F tetramagnesium;tetracarbonate Chemical compound [Mg+2].[Mg+2].[Mg+2].[Mg+2].[O-]C([O-])=O.[O-]C([O-])=O.[O-]C([O-])=O.[O-]C([O-])=O OGWLTJRQYVEDMR-UHFFFAOYSA-F 0.000 claims description 12
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 9
- 229930003756 Vitamin B7 Natural products 0.000 claims description 9
- 235000019156 vitamin B Nutrition 0.000 claims description 9
- 239000011720 vitamin B Substances 0.000 claims description 9
- 239000011735 vitamin B7 Substances 0.000 claims description 9
- 235000011912 vitamin B7 Nutrition 0.000 claims description 9
- 239000001888 Peptone Substances 0.000 claims description 7
- 108010080698 Peptones Proteins 0.000 claims description 7
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 7
- 235000019319 peptone Nutrition 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 7
- 235000000346 sugar Nutrition 0.000 claims description 7
- 229920001817 Agar Polymers 0.000 claims description 6
- 239000008272 agar Substances 0.000 claims description 6
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 claims description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- 240000008042 Zea mays Species 0.000 claims description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 2
- 235000005822 corn Nutrition 0.000 claims description 2
- 239000012531 culture fluid Substances 0.000 claims description 2
- 239000003002 pH adjusting agent Substances 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 2
- 239000011780 sodium chloride Substances 0.000 claims 1
- 150000008163 sugars Chemical class 0.000 claims 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 abstract description 20
- 230000012010 growth Effects 0.000 abstract description 15
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract description 11
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 abstract description 10
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 abstract description 10
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract description 8
- 239000002253 acid Substances 0.000 abstract description 6
- 229910052757 nitrogen Inorganic materials 0.000 abstract description 4
- 238000009825 accumulation Methods 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 108010009736 Protein Hydrolysates Proteins 0.000 abstract 3
- 239000002075 main ingredient Substances 0.000 abstract 3
- 230000001580 bacterial effect Effects 0.000 description 20
- 238000002703 mutagenesis Methods 0.000 description 13
- 231100000350 mutagenesis Toxicity 0.000 description 13
- 230000001360 synchronised effect Effects 0.000 description 8
- 239000000306 component Substances 0.000 description 7
- 239000011521 glass Substances 0.000 description 7
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 6
- 241000588722 Escherichia Species 0.000 description 5
- 239000001913 cellulose Substances 0.000 description 5
- 229920002678 cellulose Polymers 0.000 description 5
- 239000007789 gas Substances 0.000 description 5
- 239000002054 inoculum Substances 0.000 description 5
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 239000002504 physiological saline solution Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 230000000394 mitotic effect Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 241000186226 Corynebacterium glutamicum Species 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000001307 helium Substances 0.000 description 2
- 229910052734 helium Inorganic materials 0.000 description 2
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 2
- 239000013067 intermediate product Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- DTBNBXWJWCWCIK-UHFFFAOYSA-N phosphoenolpyruvic acid Chemical compound OC(=O)C(=C)OP(O)(O)=O DTBNBXWJWCWCIK-UHFFFAOYSA-N 0.000 description 2
- 229920002961 polybutylene succinate Polymers 0.000 description 2
- 239000004631 polybutylene succinate Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- WFJIVOKAWHGMBH-UHFFFAOYSA-N 4-hexylbenzene-1,3-diol Chemical compound CCCCCCC1=CC=C(O)C=C1O WFJIVOKAWHGMBH-UHFFFAOYSA-N 0.000 description 1
- 241000606750 Actinobacillus Species 0.000 description 1
- 241000948980 Actinobacillus succinogenes Species 0.000 description 1
- 241000722954 Anaerobiospirillum succiniciproducens Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000605008 Spirillum Species 0.000 description 1
- 230000009604 anaerobic growth Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 239000005431 greenhouse gas Substances 0.000 description 1
- 238000009655 industrial fermentation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000012533 medium component Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 description 1
- -1 poly butylene succinate Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 230000000192 social effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention relates to Escherichia coli capable of synthesizing succinic acids by utilizing cheap synthetic media to synchronously consume main ingredients of lignocellulose hydrolysate, including xylose and glucose under purely anaerobic conditions, a screening method thereof and an application. The Escherichia coli is named Escherichia coli BA405, with collection register number being CCTCCNO:M2013160. The screening method has the beneficial effects that a normal-pressure low-temperature plasma is adopted to mutagenize Escherichia coli; a synthetic medium plate is utilized to screen a strain capable of quickly growing under anaerobic conditions; the strain can grow by utilizing inorganic nitrogen sources to synchronously consume main ingredients of lignocellulose hydrolysate, including xylose and glucose under anaerobic conditions and accumulate succinic acids; Escherichia coli achieves growth by utilizing inorganic nitrogen sources to synchronously consume main ingredients of lignocellulose hydrolysate, including xylose and glucose and accumulation of succinic acids; as the original strain grows very slowly under purely anaerobic and synthetic medium conditions and the acid yield is very low, the mutant strain BA405 has great social significance and economic values.
Description
Technical field
The present invention relates to the intestinal bacteria of the pure anaerobic growth succinic acid-producing of utilized synthetic medium that a strain is obtained by Room-temperature low-pressure plasma mutagenic and breeding, and its application in fermentation industry, belong to industrial micro breeding and fermentation technical field thereof.Background technology
Succinic acid, also known as succsinic acid, is the intermediate product of tricarboxylic acid cycle, is extensively present in human body, animal, plant and microorganism.It is as outstanding C
4platform chemicals, can be used for the synthesis organic chemicals such as BDO, tetrahydrofuran (THF) and poly butylene succinate (PBS) class Biodegradable material, is thought one of biorefinery product of following 12 kinds of most worthies by USDOE.
Succinic acid is the common intermediate product in some anaerobism and amphimicrobe pathways metabolism, can obtain via the pathways metabolism of various bacteria.Production by Microorganism Fermentation succinic acid utilizes renewable resources because it has, fixing greenhouse gases CO
2the concern of people is more and more caused etc. advantage.And intestinal bacteria are simple owing to having culture condition, the features such as metabolism network is comparatively clear and definite, easily transforms, easy to operate, become the study hotspot of biological process synthesizing succinic acid in recent years.At present, the research of succinic acid industrial fermentation bacterial strain mainly concentrates on succinic acid-producing anaerobism spirillum (Anaerobiospirillum succiniciproducens), succinic acid-producing actinobacillus (Actinobacillus succinogenes), Corynebacterium glutamicum (Corynebacterium glutamicum), and intestinal bacteria (Escherichia coli) etc.Wherein Escherichia coli due to genetic background clear, genetic manipulation is simple, and fast growth, easy-regulating and used medium are comparatively cheap, become the study hotspot of Biological preparation succinic acid in recent years.
Intestinal bacteria when oxygen lacks, the main the way of production of succinic acid be glucose through Embden-Meyerhof-Parnaspathway through generating phosphoenolpyruvic acid, and and then metabolism synthesis oxaloacetic acid, oxysuccinic acid, fumaric acid, finally accumulate with the form of succinic acid.People's reports such as G.N.Vemuri utilize the method for intestinal bacteria two benches fermentation succinic acid-producing, and principle is two-stage is that thalline obtains Rapid Accumulation, then transfers anaerobism to and makes thalline produce a large amount of succinic acid.But in two benches fermenting process, need to consume the growth of a large amount of nutritive ingredients for thalline, succinic acid total yield is caused to decline, simultaneously because thalline grow aerobically requires higher to dissolved oxygen, higher energy consumption required for stirring and cooling etc. and cost drop into, therefore, a step anaerobically fermenting succinic acid-producing receives increasing concern.But under pure anaerobic condition, intestinal bacteria produce succinic acid needs the compound nitrogen source such as yeast powder, peptone as medium component, with inorganic nitrogen-sourced (NH
4)
2hPO
4the synthetic medium etc. of composition is compared, and price is too expensive, for this reason, needs, by further screening production bacterial strain, to obtain the production bacterial strain that synthetic medium can be utilized to grow synthesizing succinic acid.
The applicant at first patent Chinese patent application bacterial strain BA305(publication number CN102643775A, deposit number CCTCCNO:M2012102), this bacterial strain can be under anaerobic, utilize complex medium synchronous consumption ligno-cellulose hydrolysate main component xylose and glucose synthesizing succinic acid, but a small amount of succinic acid can only be accumulated in synthetic medium, therefore, the present invention is on the basis of this application, pass through strain improvement, make BA305 can utilize cheap synthetic medium synchronous consumption ligno-cellulose hydrolysate main component xylose and glucose synthesizing succinic acid under pure anaerobic condition, in succinic acid manufacture from now on, there is far-reaching significance.
Summary of the invention
One of the technical problem to be solved in the present invention is that cultivation one strain can utilize the intestinal bacteria of cheap synthetic medium synchronous consumption ligno-cellulose hydrolysate main component xylose and glucose synthesizing succinic acid under pure anaerobic condition, provides this colibacillary screening method simultaneously.
In order to solve the problems of the technologies described above, the technical solution used in the present invention is as follows:
One, the present invention has cultivated the intestinal bacteria that a strain can utilize cheap synthetic medium synchronous consumption ligno-cellulose hydrolysate main component xylose and glucose synthesizing succinic acid under pure anaerobic condition, its Classification And Nomenclature is colon bacillus (Escherichia coli) BA405, and its preserving number registration number is: CCTCCNO:M2013160.
Two, the invention provides the described screening method utilizing intestinal bacteria (Escherichia coli) BA405 of cheap synthetic medium synchronous consumption ligno-cellulose hydrolysate main component xylose and glucose synthesizing succinic acid under pure anaerobic condition.
Screening method of the present invention adopts colibacillary starting strain BA305 after plasma body mutagenesis, screening obtains under anaerobic can utilizing synthetic medium, the bacterial strain of synchronous consumption xylose and glucose mixing sugar growth, then obtain through the screening of anaerobism shake flask fermentation can the aimed strain of high-yield succinic.
Wherein, the described intestinal bacteria bacterium that sets out is BA305, deposit number CCTCCNO:M2012102.
Screen thalline step more specifically as follows:
1, plasma mutagenesis: intestinal bacteria starting strain is activated in test tube, 37 DEG C, 200r/min, incubated overnight.The bacterium liquid stroke-physiological saline solution obtained is diluted to OD
600=1.0, drip on aseptic slide glass, dry up with sterile wind; Take helium as discharge gas, with 80 ~ 120W for radio frequency power, using 10 ~ 30SLM as gas flow, with 10 ~ 20s for irradiation time, plasma body mutagenesis is carried out to bacterial strain;
2, the dull and stereotyped primary dcreening operation of synthetic medium: the tool plug test tube slide glass after mutagenesis being placed in the physiological saline that 1ml is housed, concuss, by the bacterium liquid wash-out on slide glass, is diluted to different concentration and coats on synthetic medium flat board, 37 DEG C of Anaerobic culturel 24h.Select growth comparatively large, comparatively full bacterium colony;
3, the multiple sieve of synthetic medium flat board: by step 2) in the bacterial strain that screens on synthetic medium repeatedly turning point cultivate, 37 DEG C of Anaerobic culturel 24h, select growth comparatively large, comparatively full bacterium colony;
4, anaerobism shake flask fermentation screening: by the inoculation that filters out in step 3) to enlarged culturing in seed culture medium, 37 DEG C, 200r/min, cultivate 6h, then ferment in the fermentation medium, inoculum size is 2%(v/v), 37 DEG C, 200r/min, cultivates 48h; Investigate in the bacterium colony filtered out in step 3) and filter out fast growth, produce the bacterial strain that acid amount is high.
In above-mentioned screening method, in the plasma body mutagenesis method described in step 1), selection 100W is radio frequency power, and 20SLM is gas flow, and 15s is irradiation time.
Invention further provides the application of above-mentioned intestinal bacteria in fermentation production of succinic acid.
Particularly, utilize the step of above-mentioned Escherichia coli fermentation production succinic acid as follows:
(1) slat chain conveyor: colon bacillus (Escherichia coli) BA405 is seeded in Anaerobic culturel on plate culture medium, and culture temperature is 37 DEG C, and incubation time is 24h;
(2) seed culture: be inoculated in seed culture medium by colon bacillus (Escherichia coli) BA405 of slat chain conveyor, 500ml triangular flask liquid amount 100ml, culture temperature is 37 DEG C, 200r/min, and incubation time is 6h;
(3) fermentation production of succinic acid: seed culture fluid is inoculated in fermention medium, 100ml anaerobism shaking flask liquid amount is 30ml, magnesium basic carbonate as pH adjusting agent, carbonating 2min; Culture temperature is 37 DEG C, 200r/min, and incubation time is 48-96h.
In the method for above-mentioned fermentation production of succinic acid,
The formula of seed culture medium comprises: peptone 10g/L, yeast powder 5g/L, NaCl5g/L.
Solid synthetic medium flat board formula is: citric acid 3gL
-1, Na
2hPO
412H
2o4gL
-1, KH
2pO
48gL
-1, (NH
4)
2hPO
48gL
-1, NH
4cl0.2gL
-1, (NH
4)
2sO
40.75gL
-1, MgSO
47H
2o1gL
-1, CaCl
22H
2o10.0mgL
-1, ZnSO
47H
2o0.5mgL
-1, CuCl
22H
2o0.25mgL
-1, MnSO
4h
2o2.5mgL
-1, CoCl
26H
2o1.75mgL
-1, H
3bO
30.12mgL
-1, Al
2(SO4)
31.77mgL
-1, Na
2moO
42H
2o0.5mgL
-1, ironic citrate 16.1mgL
-1, vitamins B
140mgL
-1, vitamin H 4mg.L
-1, agar 15g/L, glucose 5g/L, wood sugar 5g/L, pH7.
Application of the present invention, in step 3 fermentation culture, with the wood sugar of 1:1 and glucose or corn hydrolyzed solution for carbon source.
Particularly, fermentative medium formula is: citric acid 3gL
-1, Na
2hPO
412H
2o4gL
-1, KH
2pO
48gL
-1, (NH
4)
2hPO
48gL
-1, NH
4cl0.2gL
-1, (NH
4)
2sO
40.75gL
-1, MgSO
47H
2o1gL
-1, CaCl
22H
2o10.0mgL
-1, ZnSO
47H
2o0.5mgL
-1, CuCl
22H
2o0.25mgL
-1, MnSO
4h
2o2.5mgL
-1, CoCl
26H
2o1.75mgL
-1, H
3bO
30.12mgL
-1, Al
2(SO4)
31.77mgL
-1, Na
2moO
42H
2o0.5mgL
-1, ironic citrate 16.1mgL
-1, vitamins B
140mgL
-1, vitamin H 4mg.L
-1, magnesium basic carbonate 16g/L, glucose 10g/L, wood sugar 10g/L;
Or citric acid 3gL
-1, Na
2hPO
412H
2o4gL
-1, KH
2pO
48gL
-1, (NH
4)
2hPO
48gL
-1, NH
4cl0.2gL
-1, (NH
4)
2sO
40.75gL
-1, MgSO
47H
2o1gL
-1, CaCl
22H
2o10.0mgL
-1, ZnSO
47H
2o0.5mgL
-1, CuCl
22H
2o0.25mgL
-1, MnSO
4h
2o2.5mgL
-1, CoCl
26H
2o1.75mgL
-1, H
3bO
30.12mgL
-1, Al
2(SO4)
31.77mgL
-1, Na
2moO
42H
2o0.5mgL
-1, ironic citrate 16.1mgL
-1, magnesium basic carbonate 16g/L, wood sugar 15g/L, glucose 15g/L;
Or citric acid 3gL
-1, Na
2hPO
412H
2o4gL
-1, KH
2pO
48gL
-1, (NH
4)
2hPO
48gL
-1, NH
4cl0.2gL
-1, (NH
4)
2sO
40.75gL
-1, MgSO
47H
2o1gL
-1, CaCl
22H
2o10.0mgL
-1, ZnSO
47H
2o0.5mgL
-1, CuCl
22H
2o0.25mgL
-1, MnSO
4h
2o2.5mgL
-1, CoCl
26H
2o1.75mgL
-1, H
3bO
30.12mgL
-1, Al
2(SO4)
31.77mgL
-1, Na
2moO
42H
2o0.5mgL
-1, ironic citrate 16.1mgL
-1, magnesium basic carbonate 16g/L, containing the Corncob hydrolysate of 30g/L reducing sugar.
Beneficial effect of the present invention is:
The present invention, with atmospheric low-temperature plasma mutagenesis intestinal bacteria, filters out and synthetic medium under anaerobic can be utilized to grow fast, and the bacterial strain of high-yield succinic.This bacterial strain can take inorganic nitrogen as nitrogenous source, and under anaerobic synchronous consumption glucose and xylose grows fast, and accumulates a large amount of succinic acid; In 1.5L anaerobic fermentation tank, utilize synthetic medium, acid is produced in Corncob hydrolysate growth, and 96h cell density reaches OD
600=3.07, succinic acid output is 25g/L, and original starting strain is extremely slow at this conditioned growth, and therefore this bacterial strain has great social effect and economic worth.
Accompanying drawing explanation
Fig. 1 is colibacillary plasma body mutagenesis Survival curves;
Fig. 2 is that mutant strain BA405 utilizes synthetic medium mixing sugar one step anaerobically fermenting 96h experimental result graphic representation;
Fig. 3 is that mutant strain BA405 utilizes synthetic medium Corncob hydrolysate one step anaerobically fermenting 96h experimental result graphic representation.
Embodiment
Microorganism classification called after colon bacillus (Escherichia coli) BA405 of the present invention, be preserved in China typical culture collection center on April 25th, 2013 and (be called for short CCTCC, address: China. Wuhan. Wuhan University), deposit number is CCTCCNO:M2013160.
According to following examples, can better understand the present invention.Concrete material proportion described in case study on implementation, processing condition and result thereof only for illustration of the present invention, and should can not limit the present invention described in detail in claims yet.
Embodiment 1
The present embodiment illustrates the method for intestinal bacteria original strain being carried out the mutagenesis of the first step plasma body.
The method that intestinal bacteria starting strain carries out the mutagenesis of the first step plasma body is as follows:
Original strain intestinal bacteria BA305 is activated in LB test tube, 37 DEG C, 200r/min incubated overnight; Get the cell dilution of fresh culture to cell concn OD
600=1.0, drip on aseptic slide glass, dry up with sterile wind; Take helium as discharge gas, with 80 ~ 120W for radio frequency power, using 10 ~ 30SLM as gas flow, with 10 ~ 30s for irradiation time, plasma body mutagenesis is carried out to bacterial strain; After mutagenesis, the stroke-physiological saline solution of the mycoderm 1ml on slide glass is eluted, is coated on synthetic medium flat board, cultivates in anaerobic box.
Embodiment 2
This example illustrates the excellent colibacillary method of screening.
Wherein, the culture medium prescription used is as follows:
(1) plate culture medium: citric acid 3gL
-1, Na
2hPO
412H
2o4gL
-1, KH
2pO
48gL
-1, (NH
4)
2hPO
48gL
-1, NH
4cl0.2gL
-1, (NH
4)
2sO
40.75gL
-1, MgSO
47H
2o1gL
-1, CaCl
22H
2o10.0mgL
-1, ZnSO
47H
2o0.5mgL
-1, CuCl
22H
2o0.25mgL
-1, MnSO
4h
2o2.5mgL
-1, CoCl
26H
2o1.75mgL
-1, H
3bO
30.12mgL
-1, Al
2(SO4)
31.77mgL
-1, Na
2moO
42H
2o0.5mgL
-1, ironic citrate 16.1mgL
-1, vitamins B
140mgL
-1, vitamin H 4mg.L
-1, agar 15g/L, glucose 5g/L, wood sugar 5g/L, pH7.
(2) seed culture medium: peptone 10g/L, yeast powder 5g/L, NaCl5g/L.
(3) Medium of shaking flask fermentation: citric acid 3gL
-1, Na
2hPO
412H
2o4gL
-1, KH
2pO
48gL
-1, (NH
4)
2hPO
48gL
-1, NH
4cl0.2gL
-1, (NH
4)
2sO
40.75gL
-1, MgSO
47H
2o1gL
-1, CaCl
22H
2o10.0mgL
-1, ZnSO
47H
2o0.5mgL
-1, CuCl
22H
2o0.25mgL
-1, MnSO
4h
2o2.5mgL
-1, CoCl
26H
2o1.75mgL
-1, H
3bO
30.12mgL
-1, Al
2(SO4)
31.77mgL
-1, Na
2moO
42H
2o0.5mgL
-1, ironic citrate 16.1mgL
-1, vitamins B
140mgL
-1, vitamin H 4mg.L
-1, magnesium basic carbonate 16g/L, glucose 10g/L, wood sugar 10g/L.
Screening step:
1, the dull and stereotyped primary dcreening operation of synthetic medium
Slide glass after mutagenesis is placed in the tool plug test tube that 1ml physiological saline is housed, concuss, elutes completely by the thalline on slide glass, being diluted to different concentration coats on synthetic medium flat board, 37 DEG C of Anaerobic culturel 24h, pick out and select fast growth, comparatively full bacterium colony.
2, the multiple sieve of synthetic medium flat board
By the bacterial strain turning point cultivation repeatedly on flat board screened, finally obtain bacterial strain BA403, BA405, B411 and BA423 shows stronger growth velocity and growth stability.
3, shake flask fermentation screening
4, by bacterial strain BA403, BA405, B411 and BA423 accesses enlarged culturing in seed culture medium, 37 DEG C, 200r/min, cultivates 48h.Then be inoculated in fermention medium, 100ml anaerobism serum bottle liquid amount 30ml, inoculum size 2%(v/v), carbonating 2min, 37 DEG C, 200r/min, cultivates 48h.Detect each bacterial strain cell density and succinic acid output as shown in table 1:
The growth of table 1 mutant strain and starting strain and productivity ratio are comparatively
Under pure anaerobic condition, the starting strain speed of growth is extremely slow, and the accumulation of succinic acid is also very low, but after the mutagenesis of normal temperature low-voltage plasma, obtain the bacterial strain that can synthetic medium be utilized to grow fast under pure anaerobic condition.Through shake flask fermentation screening, the strain growth speed of BA405 is very fast, and product acid is higher.
Embodiment 3
The present embodiment illustrates the mitotic stability of mutant strain BA405
On synthetic medium flat board, cultivated by mutant strain BA405 many turning points, and will obtain bacterial strain and carry out fermentation respectively and verify, experimental result is as shown in table 2:
Table 2 mutant strain BA405 mitotic stability is analyzed
From experimental result, through 8 continuous passages, succinic acid output and the succinic acid transformation efficiency of mutant strain BA405 are all comparatively stable, have good mitotic stability, can be used as the production bacterial classification of research and development further.
Embodiment 4
The present embodiment illustrates the technique of colon bacillus EscherichiacoliBA405 fermentation production of succinic acid
Culture medium prescription described in the present embodiment:
Plate culture medium: citric acid 3gL
-1, Na
2hPO
412H
2o4gL
-1, KH
2pO
48gL
-1, (NH
4)
2hPO
48gL
-1, NH
4cl0.2gL
-1, (NH
4)
2sO
40.75gL
-1, MgSO
47H
2o1gL
-1, CaCl
22H
2o10.0mgL
-1, ZnSO
47H
2o0.5mgL
-1, CuCl
22H
2o0.25mgL
-1, MnSO
4h
2o2.5mgL
-1, CoCl
26H
2o1.75mgL
-1, H
3bO
30.12mgL
-1, Al
2(SO4)
31.77mgL
-1, Na
2moO
42H
2o0.5mgL
-1, ironic citrate 16.1mgL
-1, vitamins B
140mgL
-1, vitamin H 4mg.L
-1, agar 15g/L, glucose 5g/L, wood sugar 5g/L, pH7.
Seed culture medium: peptone 10g/L, yeast powder 5g/L, NaCl5g/L.
Fermention medium: citric acid 3gL
-1, Na
2hPO
412H
2o4gL
-1, KH
2pO
48gL
-1, (NH
4)
2hPO
48gL
-1, NH
4cl0.2gL
-1, (NH
4)
2sO
40.75gL
-1, MgSO
47H
2o1gL
-1, CaCl
22H
2o10.0mgL
-1, ZnSO
47H
2o0.5mgL
-1, CuCl
22H
2o0.25mgL
-1, MnSO
4h
2o2.5mgL
-1, CoCl
26H
2o1.75mgL
-1, H
3bO
30.12mgL
-1, Al
2(SO4)
31.77mgL
-1, Na
2moO
42H
2o0.5mgL
-1, ironic citrate 16.1mgL
-1, magnesium basic carbonate 16g/L, glucose 10g/L, wood sugar 10g/L.
Concrete grammar: colon bacillus Escherichia coliBA405 is applied to plate culture medium, cultivates in anaerobic box, culture temperature 37 DEG C, incubation time 24h.The BA405 of slat chain conveyor is inoculated in seed culture medium, 500ml triangular flask liquid amount 100ml, culture temperature 37 DEG C, 200r/min, incubation time 6h; Seed is inoculated in fermention medium, inoculum size 2%(v/v), 100ml serum bottle liquid amount 30ml, carbonating 2min, the output detecting succinic acid after fermentation culture 48h is 7.88g/L, and succinic acid transformation efficiency is 89%.
Embodiment 5
The present embodiment illustrates that colon bacillus Escherichia coliBA405 utilizes simulation that wood sugar and glucose ratio are 1:1 sugared for carbon source through fermentation produces the technique of succinic acid
Culture medium prescription described in the present embodiment:
Plate culture medium: citric acid 3gL
-1, Na
2hPO
412H
2o4gL
-1, KH
2pO
48gL
-1, (NH
4)
2hPO
48gL
-1, NH
4cl0.2gL
-1, (NH
4)
2sO
40.75gL
-1, MgSO
47H
2o1gL
-1, CaCl
22H
2o10.0mgL
-1, ZnSO
47H
2o0.5mgL
-1, CuCl
22H
2o0.25mgL
-1, MnSO
4h
2o2.5mgL
-1, CoCl
26H
2o1.75mgL
-1, H
3bO
30.12mgL
-1, Al
2(SO4)
31.77mgL
-1, Na
2moO
42H
2o0.5mgL
-1, ironic citrate 16.1mgL
-1, vitamins B
140mgL
-1, vitamin H 4mg.L
-1, agar 15g/L, glucose 5g/L, wood sugar 5g/L, pH7.
Seed culture medium: peptone 10g/L, yeast powder 5g/L, NaCl5g/L.
Fermention medium: citric acid 3gL
-1, Na
2hPO
412H
2o4gL
-1, KH
2pO
48gL
-1, (NH
4)
2hPO
48gL
-1, NH
4cl0.2gL
-1, (NH
4)
2sO
40.75gL
-1, MgSO
47H
2o1gL
-1, CaCl
22H
2o10.0mgL
-1, ZnSO
47H
2o0.5mgL
-1, CuCl
22H
2o0.25mgL
-1, MnSO
4h
2o2.5mgL
-1, CoCl
26H
2o1.75mgL
-1, H
3bO
30.12mgL
-1, Al
2(SO4)
31.77mgL
-1, Na
2moO
42H
2o0.5mgL
-1, ironic citrate 16.1mgL
-1, magnesium basic carbonate 16g/L, wood sugar 15g/L, glucose 15g/L.
Concrete grammar: colon bacillus Escherichia coliBA405 is applied to plate culture medium, cultivates in anaerobic box, culture temperature 37 DEG C, incubation time 24h.The BA405 of slat chain conveyor is inoculated in seed culture medium, 500ml triangular flask liquid amount 100ml, culture temperature 37 DEG C, 200r/min, incubation time 6h; Seed is inoculated in fermention medium, inoculum size 10%(v/v), 3L fermentor tank liquid amount 1.5L, CO
2flow velocity is per minute 0.2L, 200 rpms, and 37 ° of C cultivate 96h.
As shown in Figure 2, detect after fermentation culture 96h that the output of succinic acid is 23.6g/L, succinic acid transformation efficiency is 84.7% to fermentation results, and fermenting process achieves and utilizes synthetic medium synchronous consumption glucose sugar and wood sugar.
Embodiment 6
The present embodiment illustrates that colon bacillus Escherichia coliBA405 utilizes the technique of Corncob hydrolysate fermentation production of succinic acid.
Culture medium prescription described in the present embodiment:
Plate culture medium: citric acid 3gL
-1, Na
2hPO
412H
2o4gL
-1, KH
2pO
48gL
-1, (NH
4)
2hPO
48gL
-1, NH
4cl0.2gL
-1, (NH
4)
2sO
40.75gL
-1, MgSO
47H
2o1gL
-1, CaCl
22H
2o10.0mgL
-1, ZnSO
47H
2o0.5mgL
-1, CuCl
22H
2o0.25mgL
-1, MnSO
4h
2o2.5mgL
-1, CoCl
26H
2o1.75mgL
-1, H
3bO
30.12mgL
-1, Al
2(SO4)
31.77mgL
-1, Na
2moO
42H
2o0.5mgL
-1, ironic citrate 16.1mgL
-1, vitamins B
140mgL
-1, vitamin H 4mg.L
-1, agar 15g/L, wood sugar 10g/L, pH7.
Seed culture medium: peptone 10g/L, yeast powder 5g/L, NaCl5g/L.
Fermention medium: citric acid 3gL
-1, Na
2hPO
412H
2o4gL
-1, KH
2pO
48gL
-1, (NH
4)
2hPO
48gL
-1, NH
4cl0.2gL
-1, (NH
4)
2sO
40.75gL
-1, MgSO
47H
2o1gL
-1, CaCl
22H
2o10.0mgL
-1, ZnSO
47H
2o0.5mgL
-1, CuCl
22H
2o0.25mgL
-1, MnSO
4h
2o2.5mgL
-1, CoCl
26H
2o1.75mgL
-1, H
3bO
30.12mgL
-1, Al
2(SO4)
31.77mgL
-1, Na
2moO
42H
2o0.5mgL
-1, ironic citrate 16.1mgL
-1, magnesium basic carbonate 16g/L, containing the Corncob hydrolysate of 30g/L reducing sugar.The main component of Corncob hydrolysate is as shown in table 3.
The main component of table 3 Corncob hydrolysate
Concrete grammar: colon bacillus Escherichia coliBA405 is applied to plate culture medium, cultivates in anaerobic box, culture temperature 37 DEG C, incubation time 24h.The BA405 of slat chain conveyor is inoculated in seed culture medium, 500ml triangular flask liquid amount 100ml, culture temperature 37 DEG C, 200r/min, incubation time 6h; Seed is inoculated in fermention medium, inoculum size 10%(v/v), 3L fermentor tank liquid amount 1.5L, CO
2flow velocity is per minute 0.2L, 200 rpms, and 37 ° of C cultivate 96h.
As shown in Figure 3, mutant strain BA405 utilizes Corncob hydrolysate anaerobically fermenting and utilizes mixing sugar anaerobically fermenting not have larger difference fermentation results, and acetic acid is unique by product.Detect that the output of succinic acid is 25g/L after cultivating 96h, succinic acid transformation efficiency is 83.3%.
Although above the present invention is described in detail with a general description of the specific embodiments, on basis of the present invention, can make some modifications or improvements it, this will be apparent to those skilled in the art.Therefore, these modifications or improvements without departing from theon the basis of the spirit of the present invention, all belong to the scope of protection of present invention.
Claims (6)
1. a strain utilizes the intestinal bacteria of synthetic medium synthesizing succinic acid, its Classification And Nomenclature be colon bacillus (
escherichia coli) BA405, its preserving number registration number is: CCTCC NO:M 2013160.
2. the application of coli strain according to claim 1 in fermentation production of succinic acid.
3. application according to claim 2, is characterized in that described embody rule step is as follows:
(1) slat chain conveyor: by colon bacillus (
escherichia coli) BA405 is seeded in Anaerobic culturel on plate culture medium, culture temperature is 37 DEG C, and incubation time is 24 h;
(2) seed culture: by the colon bacillus of slat chain conveyor (
escherichia coli) BA405 is inoculated in seed culture medium, 500 ml triangular flask liquid amount 100 ml, culture temperature is 37 DEG C, 200 r/min, and incubation time is 6 h;
(3) fermentation production of succinic acid: seed culture fluid is inoculated in fermention medium, 100 ml anaerobism shaking flask liquid amounts are 30 ml, magnesium basic carbonate as pH adjusting agent, carbonating 2 min; Culture temperature is 37 DEG C, 200 r/min, and incubation time is 48-96h.
4. application according to claim 3, is characterized in that: the formula of described seed culture medium comprises: peptone 10 g/L, yeast powder 5 g/L, NaCl 5 g/L;
Solid synthetic medium flat board formula is: citric acid 3 gL
-1, Na
2hPO
412H
2o 4 gL
-1, KH
2pO
48 gL
-1, (NH
4)
2hPO
48 gL
-1, NH
4cl 0.2 gL
-1, (NH
4)
2sO
40.75 gL
-1, MgSO
47H
2o 1 gL
-1, CaCl
22H
2o 10.0 mgL
-1, ZnSO
47H
2o 0.5 mgL
-1, CuCl
22H
2o 0.25 mgL
-1, MnSO
4h
2o 2.5 mgL
-1, CoCl
26H
2o 1.75 mgL
-1, H
3bO
30.12 mgL
-1, Al
2(SO4)
31.77 mgL
-1, Na
2moO
42H
2o 0.5 mgL
-1, ironic citrate 16.1 mgL
-1, vitamins B
140 mgL
-1, vitamin H 4 mg.L
-1, agar 15 g/L, glucose 5 g/L, wood sugar 5 g/L, pH 7.
5. the application according to claim 3 or 4, is characterized in that: in described step 3 fermentation culture, with the wood sugar of 1:1 and glucose or corn hydrolyzed solution for carbon source.
6. the application according to claim 3 or 4, is characterized in that: described fermentative medium formula is: citric acid 3 gL
-1, Na
2hPO
412H
2o 4 gL
-1, KH
2pO
48 gL
-1, (NH
4)
2hPO
48 gL
-1, NH
4cl 0.2 gL
-1, (NH
4)
2sO
40.75 gL
-1, MgSO
47H
2o 1 gL
-1, CaCl
22H
2o 10.0 mgL
-1, ZnSO
47H
2o 0.5 mgL
-1, CuCl
22H
2o 0.25 mgL
-1, MnSO
4h
2o 2.5 mgL
-1, CoCl
26H
2o 1.75 mgL
-1, H
3bO
30.12 mgL
-1, Al
2(SO4)
31.77 mgL
-1, Na
2moO
42H
2o 0.5 mgL
-1, ironic citrate 16.1 mgL
-1, vitamins B
140 mgL
-1, vitamin H 4 mg.L
-1, magnesium basic carbonate 16 g/L, glucose 10 g/L, wood sugar 10g/L;
Or citric acid 3 gL
-1, Na
2hPO
412H
2o 4 gL
-1, KH
2pO
48 gL
-1, (NH
4)
2hPO
48 gL
-1, NH
4cl 0.2 gL
-1, (NH
4)
2sO
40.75 gL
-1, MgSO
47H
2o 1 gL
-1, CaCl
22H
2o 10.0 mgL
-1, ZnSO
47H
2o 0.5 mgL
-1, CuCl
22H
2o 0.25 mgL
-1, MnSO
4h
2o 2.5 mgL
-1, CoCl
26H
2o 1.75 mgL
-1, H
3bO
30.12 mgL
-1, Al
2(SO4)
31.77 mgL
-1, Na
2moO
42H
2o 0.5 mgL
-1, ironic citrate 16.1 mgL
-1, magnesium basic carbonate 16 g/L, wood sugar 15 g/L, glucose 15 g/L;
Or citric acid 3 gL
-1, Na
2hPO
412H
2o 4 gL
-1, KH
2pO
48 gL
-1, (NH
4)
2hPO
48 gL
-1, NH
4cl 0.2 gL
-1, (NH
4)
2sO
40.75 gL
-1, MgSO
47H
2o 1 gL
-1, CaCl
22H
2o 10.0 mgL
-1, ZnSO
47H
2o 0.5 mgL
-1, CuCl
22H
2o 0.25 mgL
-1, MnSO
4h
2o 2.5 mgL
-1, CoCl
26H
2o 1.75 mgL
-1, H
3bO
30.12 mgL
-1, Al
2(SO4)
31.77 mgL
-1, Na
2moO
42H
2o 0.5 mgL
-1, ironic citrate 16.1 mgL
-1, magnesium basic carbonate 16 g/L, containing the Corncob hydrolysate of 30 g/L reducing sugars.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310288669.0A CN103320367B (en) | 2013-07-10 | 2013-07-10 | Screening method and application of Escherichia coli for preparing high-yield succinic acids by utilizing synthetic media under anaerobic conditions |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310288669.0A CN103320367B (en) | 2013-07-10 | 2013-07-10 | Screening method and application of Escherichia coli for preparing high-yield succinic acids by utilizing synthetic media under anaerobic conditions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103320367A CN103320367A (en) | 2013-09-25 |
| CN103320367B true CN103320367B (en) | 2014-12-31 |
Family
ID=49189413
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310288669.0A Expired - Fee Related CN103320367B (en) | 2013-07-10 | 2013-07-10 | Screening method and application of Escherichia coli for preparing high-yield succinic acids by utilizing synthetic media under anaerobic conditions |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103320367B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104630290A (en) * | 2013-11-12 | 2015-05-20 | 中国石油化工股份有限公司 | Method for utilizing flocculation to prolong cycle of bacterial fermentation production of succinic acid |
| CN105820991B (en) * | 2016-04-01 | 2019-11-19 | 中国科学院上海高等研究院 | A kind of Recombinant organism |
| CN110241024A (en) * | 2019-06-13 | 2019-09-17 | 西北农林科技大学 | The screening technique of one type succinate production bacterium |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007046767A1 (en) * | 2005-10-20 | 2007-04-26 | Kris Arvid Berglund | Process for the production of succinic acid |
| WO2010115067A2 (en) * | 2009-04-02 | 2010-10-07 | University Of Florida Research Foundation, Inc. | Engineering the pathway for succinate production |
| CN102643770A (en) * | 2012-05-07 | 2012-08-22 | 南京工业大学 | Colibacillus capable of generating succinic acid by utilizing synthetic medium pure anaerobic growth and application thereof |
| CN102643775A (en) * | 2012-05-10 | 2012-08-22 | 南京工业大学 | Gene engineering bacterium for producing succinic acid, and method for producing succinic acid by fermentation by using same |
| CN102864116A (en) * | 2012-10-16 | 2013-01-09 | 南京工业大学 | Genetic engineering bacterium for producing succinic acid, and construction and application thereof |
| CN102936575A (en) * | 2012-12-05 | 2013-02-20 | 南京工业大学 | Escherichia coli LL016 and application thereof |
-
2013
- 2013-07-10 CN CN201310288669.0A patent/CN103320367B/en not_active Expired - Fee Related
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007046767A1 (en) * | 2005-10-20 | 2007-04-26 | Kris Arvid Berglund | Process for the production of succinic acid |
| WO2010115067A2 (en) * | 2009-04-02 | 2010-10-07 | University Of Florida Research Foundation, Inc. | Engineering the pathway for succinate production |
| CN102643770A (en) * | 2012-05-07 | 2012-08-22 | 南京工业大学 | Colibacillus capable of generating succinic acid by utilizing synthetic medium pure anaerobic growth and application thereof |
| CN102643775A (en) * | 2012-05-10 | 2012-08-22 | 南京工业大学 | Gene engineering bacterium for producing succinic acid, and method for producing succinic acid by fermentation by using same |
| CN102864116A (en) * | 2012-10-16 | 2013-01-09 | 南京工业大学 | Genetic engineering bacterium for producing succinic acid, and construction and application thereof |
| CN102936575A (en) * | 2012-12-05 | 2013-02-20 | 南京工业大学 | Escherichia coli LL016 and application thereof |
Non-Patent Citations (4)
| Title |
|---|
| Effect of Different Carbon Sources on the Production of Succinic Acid Using Metabolically Engineered Escherichia coli;Christian Andersson et al;《Biotechnol. Prog》;20071231;第23卷;381-388 * |
| Efficient production of succinic acid from corn stalk hydrolysates by a recombinant Escherichia coli with ptsG mutation;Dan Wang et al;《Process Biochemistry》;20110920;第46卷;365-371 * |
| 不同还原性碳源对重组大肠杆菌厌氧发酵生产丁二酸的影响;王桂兰 等;《中国酿造》;20091231(第3期);16-19 * |
| 玉米籽皮稀酸水解液脱毒发酵制备丁二酸的可行性;吴昊 等;《农业工程学报》;20091231;第25卷(第2期);267-272 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103320367A (en) | 2013-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102643770B (en) | Colibacillus capable of generating succinic acid by anaerobic growth in synthetic medium pure and application thereof | |
| CN101285047B (en) | D-lactic acid-producing strain with high optical purity and process for producing D-lactic acid by fermentation thereof | |
| CN104328064A (en) | Bacillus natto and application of Bacillus natto in fermentation production of vitamin K2 | |
| CN103992978A (en) | Leuconostoc pseudomesenteroides and method for co-producing dextran and mannitol therefrom | |
| CN102703339B (en) | High-yield arginine deiminase bacterial strain and method for producing L-citrulline by same | |
| CN105132331A (en) | Komagataeibacter nataicola and application thereof | |
| CN108624524A (en) | The bacterial strain and its separating screening method of one plant of production bacteria cellulose | |
| CN102864188A (en) | Method for producing biodiesel from lignocellulose | |
| CN110373359A (en) | A kind of streptomyces albus X-18 and the method using bacterium production epsilon-polylysine | |
| CN102864113B (en) | Strain capable of producing succinic acid, method for producing succinic acid and application thereof | |
| CN101933439A (en) | Method for improving phellinus igniarius hypha amount of submerged culture by utilizing plant oil | |
| CN105969702B (en) | Serratia marcescens RZ 21-C6 and its application | |
| CN103320367B (en) | Screening method and application of Escherichia coli for preparing high-yield succinic acids by utilizing synthetic media under anaerobic conditions | |
| CN104726381A (en) | Bacterial strain for producing L-lysine and L-lysine producing method thereof | |
| CN100558884C (en) | A kind of acid-producing Klebsiella bacterium and application thereof | |
| CN102391970B (en) | Method for producing 2, 3-butanediol and special bacillus licheniformis thereof | |
| CN104087624A (en) | Method for producing citric acid by continuous fermentation of Aspergillus niger | |
| CN105316246A (en) | Beta-carotene high-yield strain and use thereof | |
| CN103320366B (en) | Screening method and application of Escherichia coli for preparing high-yield succinic acids by utilizing synthetic media under anaerobic conditions | |
| CN104419657A (en) | D-lactic acid producing strain with high growth rate and acid producing velocity and application thereof | |
| CN103451126B (en) | High-concentration ammonium ion tolerant escherichia coli capable of producing succinic acid and application thereof | |
| CN103952447A (en) | Method for producing succinic acid by virtue of fermentation under anaerobic conditions | |
| CN102936575B (en) | Escherichia coli LL016 and application thereof | |
| CN103305437B (en) | L-ammonium lactate tolerant bacterium and application thereof | |
| CN101974452A (en) | Colimycin high-yield strain and screening method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141231 Termination date: 20150710 |
|
| EXPY | Termination of patent right or utility model |